Literature DB >> 7652009

A design study for an accelerator-based epithermal neutron beam for BNCT.

D A Allen1, T D Beynon.   

Abstract

An achievable design concept for a boron neutron capture therapy (BNCT) facility, based on a high-current, low-energy proton accelerator, is described. Neutrons are produced within a thick natural lithium target, under bombardment from protons with an initial energy between 2.5 and 3.0 MeV. The proton current will be up to 10 mA. After gamma-ray filtering, the neutrons are partially moderated to epithermal energies within a heavy-water moderator, poisoned with 6Li to remove thermal neutrons. Monte Carlo modelling has been used to predict system performance in terms of neutron fluence rate and neutron and gamma-ray dose at the patient position. The relationship between the system performance and key parameters, such as proton energy, moderator depth and 6Li concentration, has been investigated. With a proton current of 10 mA, the facility is capable of providing a therapy beam with a useful neutron fluence rate of 10(9) cm-2 s-1 and a neutron dose per unit fluence of less than 6 x 10(-13) Gy cm2, with a gamma-ray contamination of the therapy beam of about 10(-13) Gy cm2.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7652009     DOI: 10.1088/0031-9155/40/5/007

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  7 in total

1.  Present status of Accelerator-Based BNCT.

Authors:  Andres Juan Kreiner; Javier Bergueiro; Daniel Cartelli; Matias Baldo; Walter Castell; Javier Gomez Asoia; Javier Padulo; Juan Carlos Suárez Sandín; Marcelo Igarzabal; Julian Erhardt; Daniel Mercuri; Alejandro A Valda; Daniel M Minsky; Mario E Debray; Hector R Somacal; María Eugenia Capoulat; María S Herrera; Mariela F Del Grosso; Leonardo Gagetti; Manuel Suarez Anzorena; Nicolas Canepa; Nicolas Real; Marcelo Gun; Hernán Tacca
Journal:  Rep Pract Oncol Radiother       Date:  2014-12-12

Review 2.  The requirements and development of neutron beams for neutron capture therapy of brain cancer.

Authors:  R L Moss; O Aizawa; D Beynon; R Brugger; G Constantine; O Harling; H B Liu; P Watkins
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

3.  Evaluation of radioactivity in the bodies of mice induced by neutron exposure from an epi-thermal neutron source of an accelerator-based boron neutron capture therapy system.

Authors:  Satoshi Nakamura; Shoji Imamichi; Kazuyoshi Masumoto; Masashi Ito; Akihisa Wakita; Hiroyuki Okamoto; Shie Nishioka; Kotaro Iijima; Kazuma Kobayashi; Yoshihisa Abe; Hiroshi Igaki; Kazuyoshi Kurita; Teiji Nishio; Mitsuko Masutani; Jun Itami
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2017       Impact factor: 3.493

4.  Optimization of the photoneutron target geometry for e-accelerator based BNCT.

Authors:  Nahid Chegeni; Saleh Boveiry Pur; Sasan Razmjoo; Seydeh Khadijed Hoseini
Journal:  Electron Physician       Date:  2017-06-25

5.  Water-Soluble closo-Docecaborate-Containing Pteroyl Derivatives Targeting Folate Receptor-Positive Tumors for Boron Neutron Capture Therapy.

Authors:  Fumiko Nakagawa; Hidehisa Kawashima; Taiki Morita; Hiroyuki Nakamura
Journal:  Cells       Date:  2020-07-03       Impact factor: 6.600

6.  A Novel Approach to Design and Evaluate BNCT Neutron Beams Combining Physical, Radiobiological, and Dosimetric Figures of Merit.

Authors:  Ian Postuma; Sara González; Maria S Herrera; Lucas Provenzano; Michele Ferrarini; Chiara Magni; Nicoletta Protti; Setareh Fatemi; Valerio Vercesi; Giuseppe Battistoni; Umberto Anselmi Tamburini; Yuan Hao Liu; Leena Kankaanranta; Hanna Koivunoro; Saverio Altieri; Silva Bortolussi
Journal:  Biology (Basel)       Date:  2021-02-26

7.  Characterization of the relationship between neutron production and thermal load on a target material in an accelerator-based boron neutron capture therapy system employing a solid-state Li target.

Authors:  Satoshi Nakamura; Hiroshi Igaki; Masashi Ito; Hiroyuki Okamoto; Shie Nishioka; Kotaro Iijima; Hiroki Nakayama; Mihiro Takemori; Shoji Imamichi; Tairo Kashihara; Kana Takahashi; Koji Inaba; Kae Okuma; Naoya Murakami; Yoshihisa Abe; Yuko Nakayama; Mitsuko Masutani; Teiji Nishio; Jun Itami
Journal:  PLoS One       Date:  2019-11-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.